Santhera’s Agamree becomes first approved treatment in UK for all DMD patients
The UK nod for Agamree, which comes after previous approvals in Europe and the US, provides access to a corticosteroid with less severe side effects.
The UK nod for Agamree, which comes after previous approvals in Europe and the US, provides access to a corticosteroid with less severe side effects.
What's Your Reaction?
